COAG Hemab Therapeutics Holdings, Inc.

NASDAQ
$39.15

Hemab Therapeutics Holdings, Inc. (COAG) Earnings News

Earnings press releases, previews and reviews for Hemab Therapeutics Holdings, Inc. (COAG), newest first. Our most recent is preview: Hemab Faces a Narrower Loss Forecast as Souring Sentiment Raises the Stakes.